Revium Rx (RVRC)
OTCMKTS · Delayed Price · Currency is USD
0.5200
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT

Revium Rx Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2009FY 2008
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '09 Dec '08
Cash & Equivalents
3.913.271.190.4300.02
Short-Term Investments
1.022.010.01---
Cash & Short-Term Investments
4.935.281.190.4300.02
Cash Growth
14607.99%342.50%180.05%54938.76%-95.14%-
Accounts Receivable
----0.020.29
Other Receivables
-0.040.150.01--
Receivables
-0.040.150.010.020.29
Inventory
----0.11-
Prepaid Expenses
-0.170.210.0200.03
Other Current Assets
0.270.020---
Total Current Assets
5.25.521.560.460.130.33
Property, Plant & Equipment
0.010.010002
Goodwill
11.4111.41--0.32.9
Other Intangible Assets
3.343.34--0.580.88
Long-Term Deferred Charges
----0.38-
Other Long-Term Assets
-----00.57
Total Assets
19.9720.281.560.461.396.68
Accounts Payable
0.140.140.050.050.320.25
Accrued Expenses
-0.210.1--0.01
Short-Term Debt
00-0--
Other Current Liabilities
0.200.010.02--
Total Current Liabilities
0.550.580.170.070.320.26
Long-Term Debt
----0.20.31
Total Liabilities
0.550.580.170.070.520.57
Common Stock
0.060.0600.030.020.03
Additional Paid-In Capital
30.6930.393.3150.886
Retained Earnings
-12.15-11.51-1.92-4.64-0.030.07
Total Common Equity
18.618.941.390.390.876.11
Minority Interest
0.810.77----
Shareholders' Equity
19.4119.711.390.390.876.11
Total Liabilities & Equity
19.9720.281.560.461.396.68
Total Debt
00-00.20.31
Net Cash (Debt)
4.935.281.190.43-0.2-0.29
Net Cash Growth
-342.41%180.71%---
Net Cash Per Share
0.080.090.040.02-3.42-4.25
Filing Date Shares Outstanding
60.7360.7357.9328.110.070.07
Total Common Shares Outstanding
60.7360.7334.7628.110.070.07
Working Capital
4.654.941.390.39-0.190.07
Book Value Per Share
0.310.310.040.0112.4788.49
Tangible Book Value
3.854.181.390.39-0.012.33
Tangible Book Value Per Share
0.060.070.040.01-0.1433.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.